For The Better

The Food and Drug Administration recently approved a new vaccine from Moderna, but the stock dipped in response.

These stocks now make up a sizable chunk of Bridgewater Associates’ portfolio.

This tech company is down and out today, but its products could see massive adoption in the future.

The AI giant could have clear sailing ahead thanks to one key factor.

This trick only works in certain scenarios.

This company pioneered one popular approach to cloud security.

Before you get sucked in by Annaly Capital’s huge 13%-plus dividend yield, you’ll want to take a look at the risk of a dividend cut.

There is a clear winner in this battle of the online brokers.

These ETFs are an easy way to turn small but regular contributions into a $1 million retirement fund.

Here’s why the stock fell despite strong results and raised guidance.

Looking to give your portfolio a boost? Look no further.

These stocks look cheap despite their excellent long-term opportunities.

Three high-flying stocks, which all recently announced stock splits, might come crashing back to reality.

The high yield could signal a real value for dividend investors.

The Roundhill Magnificent Seven ETF is a product that Wall Street is selling, but that you probably shouldn’t be buying.

The company has options when it comes to using cash.

The cloud software giant just disappointed a lot of investors.

The Oracle of Omaha oversees 44 stocks in a $375 billion portfolio for Berkshire Hathaway. Three of these stocks are extraordinary values right now.

It’s not enough just to spot the big trends because those trends won’t benefit all businesses equally.

This news could be worth billions…